BioLineRx Announces Clinical Research Collaboration to Investigate Combination of BL-8040 with Atezolizumab in Multiple Oncology Indications

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. SPY
2. EYPT
3. GNK
4. NVDA
5. AZN
6. SPCX
7. FNGR
8. PLUR
9. HIVE
10. GSAT

Go back to BioLineRx Announces Clinical Research Collaboration to Investigate Combination of BL-8040 with Atezolizumab in Multiple Oncology Indications
Bioline RX Ltd Ordinary shares (AMEX: BLNEF) Delayed: 0.86 --0 (-0%)
Previous Close $0.86    52 Week High $1.54 
Open $1.64    52 Week Low $1.15 
Day High $0.86    P/E N/A 
Day Low $0.86    EPS $0.00 
Volume 1,500       

Bioline RX Ltd Ordinary shares (AMEX: BLNEF) Delayed: 0.86 --0 (-0%)
Previous Close $0.86    52 Week High $1.54 
Open $1.64    52 Week Low $1.15 
Day High $0.86    P/E N/A 
Day Low $0.86    EPS $0.00 
Volume 1,500       

BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.71 -0.05 (1.81%)
Previous Close $2.76    52 Week High $1.63 
Open $2.76    52 Week Low $0.71 
Day High $2.86    P/E N/A 
Day Low $2.71    EPS $0.00 
Volume 6,934       

BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.71 -0.05 (1.81%)
Previous Close $2.76    52 Week High $1.63 
Open $2.76    52 Week Low $0.71 
Day High $2.86    P/E N/A 
Day Low $2.71    EPS $0.00 
Volume 6,934